Supplements and Warfarin: Interactions That Can Cause Bleeding

Warfarin (Coumadin) is the world's most widely prescribed anticoagulant — taken by millions of people with atrial fibrillation, mechanical heart valves, deep vein thrombosis, and pulmonary embolism. It works by blocking vitamin K-dependent clotting factor synthesis. The therapeutic window is deliberately narrow: too little anticoagulation allows clot formation; too much causes bleeding. Patients are monitored with INR (International Normalized Ratio) tests every 2–4 weeks, and small changes in dietary vitamin K intake or drug/supplement interactions can push them out of range.

A 2016 survey of warfarin patients found that 69% were also taking at least one dietary supplement, and fewer than half had disclosed this to their anticoagulation clinic. This disclosure gap is dangerous. Unlike most drug-supplement interactions that produce modest clinical effects, warfarin interactions can be life-threatening: supratherapeutic INR (too anticoagulated) can cause intracranial hemorrhage; subtherapeutic INR (too little anticoagulation) allows stroke or pulmonary embolism. The stakes make this the highest-priority drug interaction to understand in supplement medicine.

Supplements That Increase Warfarin Effect (Raise INR)

These supplements increase the anticoagulant effect of warfarin — in other words, they thin the blood further and raise bleeding risk. The mechanisms vary but include CYP2C9 inhibition (warfarin's primary metabolic enzyme), displacement from plasma protein binding, direct antiplatelet effects that compound bleeding risk, or salicylate-mediated vitamin K antagonism.

Danshen (Salvia miltiorrhiza) — A widely used Chinese herbal supplement, danshen significantly inhibits CYP2C9 and can more than double INR. Case reports document serious hemorrhage. This interaction is considered high-severity and warfarin patients should not take danshen.

St. John's Wort — One of the most thoroughly documented herbal drug interactions in medicine. St. John's Wort induces CYP3A4 and P-glycoprotein, dramatically increasing warfarin clearance and reducing its effect. It typically reduces INR by 30–70%, converting therapeutic anticoagulation to subtherapeutic and substantially increasing stroke/thrombosis risk. This interaction is listed in warfarin's official prescribing information as a contraindication. Patients on warfarin must not take St. John's Wort.

Coenzyme Q10 (CoQ10) — CoQ10 has a structural similarity to vitamin K and can reduce warfarin's effectiveness, lowering INR. Several case reports and one crossover trial documented significant INR reductions. The effect is variable but can be clinically meaningful, particularly at doses above 100 mg/day.

Garlic (high-dose supplements) — Garlic has direct antiplatelet activity and may inhibit CYP2C9 at supplemental doses (not typical dietary intake). Case reports document increased bleeding with warfarin coadministration. The interaction is dose-dependent; raw garlic in cooking is generally not a concern, but standardized garlic extracts at 600–900 mg/day warrant caution.

Ginger (high-dose) — At supplemental doses (above 1 g/day), ginger has significant antiplatelet activity via thromboxane inhibition. Combined with warfarin, this can produce additive bleeding risk even without changing INR — a case of pharmacodynamic rather than pharmacokinetic interaction.

Supplements That Reduce Warfarin Effect (Lower INR)

Vitamin K supplements — The most straightforward interaction: vitamin K directly counters warfarin's mechanism. Even small consistent increases in vitamin K intake (supplemental or dietary) will lower INR. Patients on warfarin should maintain consistent vitamin K intake and notify their anticoagulation clinic before starting any supplement containing vitamin K, including multivitamins, greens powders, and vitamin K2 products.

Green tea extract — Contains substantial vitamin K (particularly in high-concentration extracts) and can reduce INR. Brewed green tea in normal quantities is not a significant concern, but concentrated extract capsules may be.

Ginseng (Asian/Panax) — American ginseng (Panax quinquefolius) was shown in a 2004 RCT to significantly reduce warfarin's AUC and lower INR by 34% over 3 weeks. Asian ginseng (Panax ginseng) has similar but possibly less pronounced effects. Both should be avoided in warfarin patients.

The Vitamin K2 Question

Vitamin K2 supplements (as MK-4 or MK-7) present a specific dilemma: they have genuine evidence for bone and cardiovascular health benefits, but they are vitamin K and they will interfere with warfarin. MK-7 has a particularly long half-life (72 hours) and accumulates with daily supplementation, producing consistent INR lowering. Some anticoagulation clinics work with patients to accommodate a fixed K2 dose (allowing warfarin dose adjustment), but this requires coordination. Patients should not start vitamin K2 without discussing it with their anticoagulation provider.

What to Do If You Are on Warfarin

Disclose all supplements to your anticoagulation clinic or prescribing physician — including products you consider food (protein powders, greens powders, herbal teas). Do not start or stop supplements without notification, as even cessation of a stable supplement will change your INR. If you start a new supplement, request an INR check 5–7 days later to identify any significant interaction early. Avoid St. John's Wort and danshen entirely. Maintain consistent intake of vitamin K-containing supplements and foods rather than variable intake — consistency is safer than elimination, because INR can be adjusted to a stable baseline but not to a moving target. Newer anticoagulants (DOACs: rivaroxaban, apixaban, dabigatran) have fewer herbal interactions than warfarin and do not require INR monitoring, though they have their own supplement interaction profiles worth reviewing.